Rockville, MD, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The global Clostridium difficile infection treatment market has been estimated at US$ 1.24 billion for 2024 and is projected to expand at a CAGR of 6.3 ...

Newswise — Every time we take antibiotics—whether it’s for strep throat, urinary tract infections, or pneumonia —there is a slim chance that “bad” bacteria can move in and wreak havoc on our digestive ...

There are inherent risks in biotech investing. A decade’s worth and often hundreds of millions of dollars in R&D, along with binary risks of failed clinical trials or regulatory approval. Above and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

C. diff is a horrible disease that can cause significant morbidity. It can and often does recur and kills around 30,000 Americans every year. We have made progress in prevention and treatment, but ...

The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C. diff), may not be living up to its promise, according to new research. The ...

Newswise — HOUSTON – (March 13, 2017) – Frozen and freeze-dried products for Fecal Microbiota Transplantation (FMT) are nearly as effective as fresh product at treating patients with Clostridium ...

C. diff, which is short for Clostridioides difficile, is a type of bacteria that may cause serious problems in the digestive system. It is one of the most common causes of diarrhea linked to ...

Fever, nausea, cramping, and diarrhea — if you have ulcerative colitis (UC), you probably know that those symptoms signal a flare. The same symptoms can also be a Clostridioides difficile (C. diff) ...

Keith Kaye, MD, MPH, explains how shorter antibiotic courses and optimized dosing help balance treatment efficacy against C. diff risk. This is why hospitals, researchers, and clinicians have worked ...